NCI awards $1.5M for development of companion Dx test for melanoma

09/26/2013 | GenomeWeb Daily News (free registration)

The National Cancer Institute has awarded BioMarker Strategies a $1.5 million grant to advance the development of its PathMap test, a companion diagnostic assay for melanoma. The company also will use the grant to finance its efforts to validate the assay in human clinical specimens.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY